Osteoporosis after adjuvant treatment for early-stage breast cancer.

Cancer shared this article with you from Inoreader Osteoporosis after adjuvant treatment for early-stage breast cancer. Via MedWorm Cancer & Oncology Research CONCLUSIONS: Adjuvant anthracycline-taxane-based chemotherapy followed by endocrine therapy caused bone loss, especially in younger compared with older patients with early-stage breast cancer, confirming the results from randomised trials. FUNDING: This work was supported by the Region of Southern Denmark (grant number 13/7078); the University of Southern Denmark (grant number 00-101-000); the Danish Cancer Society (grant number R90-A6210-14-52); the Department of Oncology and Department of Endocrinology, Odense University Hospital; and the Consultant Council Scholarship, Odense University Hospital. TRIAL REGISTRATION: The study was approved by the Ethics Committee in Region of Southern Denmark (Project ID S-20140142) and the Danish Data Protection Board (ID 2008-58-0035). PMID... View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.